How many clinical trials are tracked for Pemphigus vulgaris?

4 trials are tracked, 1 with published results.

Mode

All Infectious Disease Oncology Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Gastroenterology Primary Care & Family Medicine Nutrition & Obesity Medicine OB/GYN & Women's Health Orthopedics & Sports Medicine Genetics & Precision Medicine Radiology & Imaging Pulmonology & Critical Care Anesthesiology & Pain Medicine Physical Medicine & Rehab Nephrology Hematology Urology Dermatology Emergency Medicine Ophthalmology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Pemphigus vulgaris

1 published article · Updated continuously

Clinical Trial Landscape

Clinical Trials for Pemphigus vulgaris

4 trials tracked for Pemphigus vulgaris: 2 in phase 3 or 4 and 1 with published results. The most-cited published study has 112 citations.

4Trials tracked

2Phase 3 & 4

0Recruiting

1With published results

Phase distribution

Phase 3 2 Phase 2 2

Phase 3 A Study to Evaluate the Efficacy and Safety of Rituximab Versus Mycophenolate Mofetil (MMF) in Participants With Pemphigus Vulgaris (PV) Completed · 112 cited
Phase 3 A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus) Completed
Phase 2 Dexamethasone Solution and Dexamethasone in Mucolox™ Completed
Phase 2 A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris Completed

Showing the 4 most-cited and recently-updated of 4 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.